Addex Therapeutics Ltd (APE)
XSTU
Closed
Oct 7, 2026
Day's Range
0.022052 wk Range
0.0166Overview - APE - Addex Therapeutics Ltd
Key Statistics
Valuation
Enterprise Value
-1.60M
P/E (Trailing)
‪-0.36‬
Price / Book
‪0.79‬
EV / EBITDA
‪0.23‬
Profitability
Operating Margin
‪-22,821.85%‬
Return on Assets
‪-105.71%‬
Return on Equity
‪-141.15%‬
Ownership
Shares Outstanding
119.31M
Price stats
50-Day Avg
‪0.0305‬
200-Day Avg
‪0.0434‬
Peers - APE - Addex Therapeutics Ltd
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- APEXSTUAddex Therapeutics Ltd-127.27%52-week change-0.37P/E (Trailing)—Profit Margin
- 0QFXSTUModerna Inc.+85.97%52-week change-23.23P/E (Trailing)‪54.83%‬Profit Margin
- 0MEXSTUTwist Bioscience Corporation+85.77%52-week change-123.50P/E (Trailing)‪50.72%‬Profit Margin
- 2LBXSTUIovance Biotherapeutics Inc.+85.40%52-week change-12.00P/E (Trailing)‪34.27%‬Profit Margin
- 3920XSTUSpyre Therapeutics, Inc.+83.21%52-week change-40.91P/E (Trailing)—Profit Margin
- 3O8XSTUOmeros Corp.+76.73%52-week change-329.00P/E (Trailing)—Profit Margin
- 7R8XSTUReplimune Group, Inc.+65.72%52-week change-3.40P/E (Trailing)—Profit Margin
Profile Summary - APE - Addex Therapeutics Ltd
About
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, specializing in the development of novel small molecule allosteric modulators for neurological disorders. These orally available drugs target receptors to offer potential therapeutic advantages over conventional…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
